Journal of Food and Drug Analysis 2018-02-21

Production of functional peptides with inhibition ability against angiotensin I-Converting enzyme using P. pastoris expression system

Hsueh-Ming Tai, Ching-Chin Li, Chun-Yu Hung, Li-Jung Yin

Index: 10.1016/j.jfda.2018.02.001

Full Text: HTML

Abstract

10.1016/j.jfda.2018.02.001 picture

To obtain the angiotension-I converting enzyme inhibitor (ACEI), a fusion ACEI polypeptide encoded with 8 DNA sequences of GPL, GPM, IKW, IVY, IRPVQ, IWHHT, IYPRY and IAPG, which were selected and designed and cloned into pGAPZαC and then transformed into Pichiapastoris SMD1168H. After 3 days induction, the fraction with highest ACEI activity was expressed and purified using a Ni Sepharose™ 6 Fast Flow. The IC50 of recombinant ACEI polypeptide was 88.2 μM. A 128-fold increase of ACEI activity (0.69 μM) was obtained after pepsin digestion, which was equivalent to 0.022 μM of captopril. Reverse phase HPLC indicated all the 8 peptides contained in ACEI-hydrolysate after pepsin digestion.